Human Immunological Diseases Section, Laboratory of Clinical Immunology and Microbiology, Intramural Research Program, National Institute of Allergy and Infectious Diseases, National Institutes of Health, United States.
Curr Opin Immunol. 2023 Feb;80:102277. doi: 10.1016/j.coi.2022.102277. Epub 2022 Dec 9.
Clinical observations and mechanistic studies in dedicator of cytokinesis 8 (DOCK8)-deficient patients and mice have revealed multiple mechanisms that could contribute to their unusually prevalent and severe allergic disease manifestations. Physical interactions of DOCK8 with STAT3 in B cells and T cells may contribute to increased IgE isotype switching or defective immune synapse formation that decreases T-cell receptor signal strength. A newly discovered T13 cell type promotes the development of life-threatening allergy via production of IL-13 and is increased in DOCK8 deficiency. Cytoskeletal derangements and cytothripsis, which were previously shown to account for the increased susceptibility to viral skin infection in DOCK8 deficiency, can lead to interplay between myeloid cells and T cells to ultimately increase production of IL-4, IL-5, and IL-13. Finally, the effects on type-2 innate lymphoid cells may also contribute to allergic disease.
临床观察和对细胞分裂蛋白 8(DOCK8)缺陷患者和小鼠的机制研究揭示了多种可能导致其异常普遍和严重过敏疾病表现的机制。DOCK8 与 B 细胞和 T 细胞中的 STAT3 的物理相互作用可能导致 IgE 同种型转换增加或免疫突触形成缺陷,从而降低 T 细胞受体信号强度。一种新发现的 T13 细胞类型通过产生 IL-13 促进危及生命的过敏的发展,并且在 DOCK8 缺陷中增加。细胞骨架紊乱和细胞碎裂,以前被认为是导致 DOCK8 缺陷中病毒皮肤感染易感性增加的原因,可导致髓样细胞与 T 细胞之间的相互作用,最终增加 IL-4、IL-5 和 IL-13 的产生。最后,对 2 型先天淋巴细胞的影响也可能导致过敏疾病。